Understanding rare cancers and raising awareness for the overlooked
Rare cancers are less known and pose challenges due to limited research and diagnostic difficulties. Environmental factors, ...
Healio4h
VIDEO: New targets sought for advanced prostate cancer treatment
In a video interview, William K. Oh, MD, director of precision medicine at Yale Cancer Center and Smilow Cancer Hospital discusses the latest breakthroughs in advanced prostate cancer treatment.
Healio4h
VIDEO: Immunotherapy may offer next big breakthrough in advanced prostate cancer
In a video interview, William K. Oh, MD, director of precision medicine at Yale Cancer Center and Smilow Cancer Hospital discusses the latest breakthroughs in advanced prostate cancer treatment.
Cure Today6h
Cabometyx Demonstrates PFS Benefit Versus Placebo in GI-NETs
Dr. Jonathan R. Strosberg, discussed results of the CABINET trial evaluating Cabometyx versus placebo in advanced ...
AdvanCell Successfully Completes an Oversubscribed US$112M Series C Financing
AdvanCell, a clinical-stage radiopharmaceutical company developing innovative cancer therapeutics, today announced the successful completion of an oversubscribed US$112 million Series C financing.